ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Gabby Thomas Partners with Babson Diagnostics’ BetterWay to Promote Accessible Healthcare

A blue and white text on a black background

Description automatically generated

 

 

 

 

 

 

 

Olympic Gold Medalist and Public Health Advocate to Raise Awareness for Routine Blood Testing

 

AUSTIN, Texas – Babson Diagnostics today announced a three-year partnership with Olympic gold medalist and public health advocate Gabby Thomas to promote accessible healthcare and raise awareness about the importance of routine blood testing through its patient-friendly BetterWay™ blood testing.

Beyond being an elite athlete, Gabby graduated from Harvard with a degree in Neuroscience and earned a Master of Public Health in Epidemiology from University of Texas, Austin. She now serves as a public health advocate, which includes directing a hypertension prevention program and volunteering at an Austin clinic serving uninsured and underserved populations.

Being at the top of her sport means Gabby keeps a close eye on her health, and that includes regular blood work. She believes everyone should have access to the same proactive monitoring. That’s why she’s partnering with Babson to promote BetterWay, which gives patients access to a broad menu of common diagnostic tests using a fingertip blood collection system that has earned high patient satisfaction ratings.

“Making healthcare more accessible is something I really care about, and BetterWay’s fingertip testing helps remove the barriers so many people face,” said Gabby Thomas. “Improving the patient experience matters, because when people feel comfortable and supported, they’re more likely to follow through with care. When care is more approachable, it can truly change lives.”

“We’re proud to partner with Gabby. She embodies the values that define Babson and BetterWay: integrity, caring, and a commitment to excellence,” said Web Golinkin, President of Babson Diagnostics. “We share her passion for public health and look forward to working closely with her to advance it.”

For more details, visit BetterWay.com or follow us on Instagram or LinkedIn

 

About BetterWayTM by Babson Diagnostics

BetterWayTM is blood testing reimagined—patient-friendly fingertip collection with accurate lab results. One in three people skip blood testing due to anxiety, fear of needles, difficult venous access, or inconvenience. BetterWay enables blood testing without phlebotomy. This improves patient experience, increases adherence to testing, optimizes staffing efficiency, and advances health equity. BetterWay was developed by Babson Diagnostics, a science-first healthcare technology company that has become the global thought leader in the use of capillary blood for routine testing. Babson was named 2024 Medtech Company of the Year by MD + DI, 2025 SXSW Innovation Award winner for Health & Biotech, and one of Fast Company’s 2025 Most Innovative Companies in Healthcare. For more information, please visit BetterWay.com or connect with us on Instagram or LinkedIn

 

Note to editors:

A biography of Gabby Thomas and high-resolution images are available at the following link.

 

Media inquiries only:

Ray Young

512.694.6097

ray@razorsharppr.com 

 

For general inquiries: discover@babsondx.com

 

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.